Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SID142 vs Rinexin in Peripheral Arterial Disease
NCT03318276Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Feb 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol + ginkgo leaf extract in Peripheral Arterial Disease (PAD), sponsored by SK Chemicals. Started Feb 2017; status: completed.
02
Drugs
cilostazol + ginkgo leaf extract
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT03318276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03318276.